Tag: PTEN‑deficient prostate cancer
-
Truqap Becomes the First Targeted Therapy for PTEN‑Deficient Metastatic Prostate Cancer
Prostate cancer remains one of the most common cancers affecting men worldwide, and while many cases respond well to early treatment, advanced forms of the disease can be far more difficult to manage. A major challenge has been finding effective therapies for aggressive subtypes that grow and spread quickly. One of these subtypes involves tumors…